You are here

Daiichi Sankyo

Doubling down on R&D, Daiichi makes executive changes across its U.S. research unit

Fierce Biotech

Fri, 02/22/19 - 11:46 am

Daiichi gets speedy FDA review for rare cancer drug

Pharmaforum

Fri, 02/8/19 - 09:38 am

priority review

Daiichi Sankyo takes option on diabetes stem cell start-up

Pharmaforum

Sat, 01/12/19 - 11:30 am

Tokyo Institute of Technology

type 1 diabetes

OiDE BetaRevive

Daiichi Sankyo lines up a $900M deal for rights to a cholesterol drug looking to disrupt a blockbuster market

Endpoints

Fri, 01/4/19 - 09:20 am

Esperion Therapeutics

Daiichi Sankyo signs clinical trial collaboration deal with Merck and Pfizer

Pharmaceutical Business Review

Fri, 10/26/18 - 09:52 am

clinical trials

Daiichi Sankyo launches phase 1 trial of DS-1205 in EGFR-mutated NSCLC

Pharmaceutical Business Review

Fri, 10/19/18 - 10:53 pm

non-small cell lung cancer

Encouraging trial results for Daiichi anti-stroke therapy

The Pharma Letter

Fri, 05/18/18 - 09:41 pm

clinical trials

atrial fibrilation

Daiichi Sankyo in pursuit of Novartis’ Rydapt with next-generation FLT3 drug

Fierce Biotech

Wed, 05/9/18 - 09:21 am

acute myeloid leukemia

Daiichi Sankyo concedes an early setback on Duchenne MD drug, but doubles down on development

Endpoints

Wed, 04/25/18 - 09:50 am

Duchenne Muscular Dystrophy

Could This be the End of Flu Shots?

CP Wire

Fri, 04/20/18 - 09:18 am

influenza vaccines

Could This be the End of Flu Shots? - Updated

Fri, 04/20/18 - 11:52 am

influenza vaccines

Top 5 boards for week ending March 10, 2018

CP Wire

Sun, 03/11/18 - 03:05 pm

3 Things In Biotech, March 8: A Tale Of 3 New Trials

Seeking Alpha

Sat, 03/10/18 - 09:26 am

clinical trials

Seattle Genetics

HER-positive colorectal cancer

Allena Pharmaceuticals

Top 5 viewed boards for week ending March 3, 2018

CP Wire

Sun, 03/4/18 - 01:50 pm

Daiichi Sankyo douses a report about an AstraZeneca buyout offer

Endpoints

Thu, 08/31/17 - 09:28 am

Daiichi Sankyo punts $650M collaboration pact as Charleston Labs preps a comeback attempt on spurned pain drug

Endpoints

Thu, 08/31/17 - 09:13 am

Charleston Laboratories

Daiichi Sankyo hands off cancer drug to Boston Pharma

BioPharma Dive

Wed, 08/30/17 - 09:58 am

Boston Pharmaceuticals

Daiichi Sankyo settles U.S. lawsuits over blood pressure drug Benicar

Reuters

Wed, 08/2/17 - 09:40 am

EMA Backs Eight New Medicines, Turns Down Drugs From Nektar & Vanda

RAPS.org

Sat, 07/22/17 - 12:23 pm

Lexicon Pharmaceuticals

Nektar’s pitch on early cancer drug OK runs into a regulatory brick wall

Endpoints

Sat, 07/22/17 - 09:57 am

Pages